NO135338B - - Google Patents
Download PDFInfo
- Publication number
- NO135338B NO135338B NO4050/72A NO405072A NO135338B NO 135338 B NO135338 B NO 135338B NO 4050/72 A NO4050/72 A NO 4050/72A NO 405072 A NO405072 A NO 405072A NO 135338 B NO135338 B NO 135338B
- Authority
- NO
- Norway
- Prior art keywords
- general formula
- succinimide
- compound
- piperidyl
- substituted
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 89
- 150000001875 compounds Chemical class 0.000 claims description 21
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical class O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims description 15
- 229960002317 succinimide Drugs 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 claims description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 6
- 238000002844 melting Methods 0.000 claims description 6
- 230000008018 melting Effects 0.000 claims description 6
- -1 succinic acid diester Chemical class 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- 230000032050 esterification Effects 0.000 claims description 5
- 238000005886 esterification reaction Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000001384 succinic acid Substances 0.000 claims description 5
- 238000006114 decarboxylation reaction Methods 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 claims description 2
- 150000002830 nitrogen compounds Chemical class 0.000 claims description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 27
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000001816 cooling Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 14
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 238000001953 recrystallisation Methods 0.000 description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical class [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 229940075930 picrate Drugs 0.000 description 3
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 3
- 229940072033 potash Drugs 0.000 description 3
- 235000015320 potassium carbonate Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethylsuccinimide Chemical compound CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 239000002026 chloroform extract Substances 0.000 description 2
- 230000001713 cholinergic effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 230000001499 parasympathomimetic effect Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003971 tillage Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- WODIALSWFWKWMM-UHFFFAOYSA-N 2,8-diazaspiro[4.5]decane-1,3-dione Chemical compound O=C1NC(=O)CC11CCNCC1 WODIALSWFWKWMM-UHFFFAOYSA-N 0.000 description 1
- GUYAGHBYTMWDLC-UHFFFAOYSA-N 2,8-dimethyl-2,8-diazaspiro[4.5]decane-1,3-dione Chemical compound O=C1N(C)C(=O)CC11CCN(C)CC1 GUYAGHBYTMWDLC-UHFFFAOYSA-N 0.000 description 1
- KETXKDIUAJXVOB-UHFFFAOYSA-N 2-methyl-2,8-diazaspiro[4.5]decane-1,3-dione Chemical compound O=C1N(C)C(=O)CC11CCNCC1 KETXKDIUAJXVOB-UHFFFAOYSA-N 0.000 description 1
- FPWYXHKGPQQAAG-UHFFFAOYSA-N 3-oxodecanal Chemical compound CCCCCCCC(=O)CC=O FPWYXHKGPQQAAG-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000287219 Serinus canaria Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- DDSZWBCJXDRQDU-UHFFFAOYSA-N [N].C1CCNCC1 Chemical group [N].C1CCNCC1 DDSZWBCJXDRQDU-UHFFFAOYSA-N 0.000 description 1
- CWVZGJORVTZXFW-UHFFFAOYSA-N [benzyl(dimethyl)silyl]methyl carbamate Chemical compound NC(=O)OC[Si](C)(C)CC1=CC=CC=C1 CWVZGJORVTZXFW-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- MLIREBYILWEBDM-UHFFFAOYSA-N anhydrous cyanoacetic acid Natural products OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- IUKQLMGVFMDQDP-UHFFFAOYSA-N azane;piperidine Chemical compound N.C1CCNCC1 IUKQLMGVFMDQDP-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical class NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000816 effect on animals Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- GHXXCVVSJXZBPO-UHFFFAOYSA-N ethyl 4-cyanobutanoate Chemical compound CCOC(=O)CCCC#N GHXXCVVSJXZBPO-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012485 toluene extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/22—Working-up of proteins for foodstuffs by texturising
- A23J3/225—Texturised simulated foods with high protein content
- A23J3/227—Meat-like textured foods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/22—Working-up of proteins for foodstuffs by texturising
- A23J3/26—Working-up of proteins for foodstuffs by texturising using extrusion or expansion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
- A23P30/30—Puffing or expanding
- A23P30/32—Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment
- A23P30/34—Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment by extrusion-expansion
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Preparation And Processing Of Foods (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Jellies, Jams, And Syrups (AREA)
- Hydrogenated Pyridines (AREA)
Description
Fremgangsmåte for fremstilling av substituerte succinimider. Process for the preparation of substituted succinimides.
Foreliggende oppfinnelse angår en fremgangsmåte for frmstilling av nye substituerte succinimider med den alminnelige formel I: The present invention relates to a process for the production of new substituted succinimides with the general formula I:
hvor R, og R., kan være like eller forskjel-lige og hver bety et hydrogenatom eller en lavere alkylgruppe. where R, and R., can be the same or different and each means a hydrogen atom or a lower alkyl group.
I henhold til oppfinnelsen blir forbin-delsene med formel I fremstillet ved at et substituert piperidon-4 med den alminnelige formel II: According to the invention, the compounds of formula I are prepared by a substituted piperidone-4 with the general formula II:
hvor R,' står for en lavere alkyl- eller en benzylgruppe, omsettes med en forbindelse med den alminnelige formel III: hvor X står for cyangruppen eller en eventuelt funksjonelt omdannet karboksyl - gruppe, i nærvær av en vannavspaltende katalysator til et piperidyliden-4-derivat med den alminnelige formel IV: hvoretter denne ved tilleiring av blåsyre overføres til en forbindelse med den alminnelige formel V: og denne ved hydrolyse, dekarboksyiering og forestring med en alkohol overføres til en substituert ravsyre-diester med den alminnelige formel VI: where R,' stands for a lower alkyl or a benzyl group, is reacted with a compound of the general formula III: where X stands for the cyano group or an optionally functionally converted carboxyl group, in the presence of a water-splitting catalyst to a piperidylidene-4- derivative with the general formula IV: after which this, by addition of hydrocyanic acid, is transferred to a compound with the general formula V: and this, by hydrolysis, decarboxylation and esterification with an alcohol, is transferred to a substituted succinic acid diester with the general formula VI:
hvoretter den dannede ester omsettes med en nitrogenforbindelse med den alminnelige formel R2 - NH„ hvor R2 har samme betydning som ovenfor og, hvis R,' står for en benzylgruppe, avspaltes denne re-duktivt og den dannede sekundære amino-gruppe eventuelt alkyleres. after which the formed ester is reacted with a nitrogen compound with the general formula R2 - NH„ where R2 has the same meaning as above and, if R,' stands for a benzyl group, this is cleaved off reductively and the secondary amino group formed is optionally alkylated.
Forbindelser med formel I, hvor R,, står for hydrogen, oppnås også, etter en variant av fremgangsmåten, ved at forbindelsen med formel V underkastes hydrolyse, dekarboksyleninig og forestring med en alkohol bare i kort tid, hvorved det dannes et substituert ravsyre-alkyl-ester-amid som ved oppvarming til over smeltepunktet eller ved koking i et opp-løsningsmlddel går over 1 et succinimid som Ikke er substituert ved nitrogenatomet. Compounds of formula I, where R,, stands for hydrogen, are also obtained, according to a variant of the method, by subjecting the compound of formula V to hydrolysis, decarboxylation and esterification with an alcohol only for a short time, whereby a substituted succinic alkyl is formed -ester amide which, when heated to above the melting point or when boiled in a solvent, undergoes a succinimide which is not substituted at the nitrogen atom.
Fremstillingen av det succinimid (formel I: R, = H) som Ikke er substituert ved piperidinnitrogenet foregår fortrinsvis over (1-benzyl-piperldyl-4)-forbindelsene med 'tilsluttende reduktiv avspalting av benzylgruppen. Til den katalytiske deben-zylering, f. eks. med hydrogen/palladium, kan både saltene og de fri baser anvendes. Succinimid-derivatet kan så alkyleres ved piperidin-nlitrogenatomet, idet det behand-les f. eks. med et lavere alifatisk aldehyd eller keton i hydrogenatmosfære i nærvær av en katalysator, eller med et alkylhalo-genid, fortrinsvis i nærvær av et alkalisk kondenserlngsmiiddel, f. eks. natriumkarbonat, eller også metyleres ved behandling med formaldehyd/maursyre. The preparation of the succinimide (formula I: R, = H) which is not substituted at the piperidine nitrogen preferably takes place over the (1-benzyl-piperidyl-4) compounds with subsequent reductive removal of the benzyl group. For the catalytic deben-zylation, e.g. with hydrogen/palladium, both the salts and the free bases can be used. The succinimide derivative can then be alkylated at the piperidine nitrogen atom, as it is treated e.g. with a lower aliphatic aldehyde or ketone in a hydrogen atmosphere in the presence of a catalyst, or with an alkyl halide, preferably in the presence of an alkaline condensing agent, e.g. sodium carbonate, or is also methylated by treatment with formaldehyde/formic acid.
Fremgangsmåten blir eksempelvis ut-ført på følgende måte: Et l-alkyl-piperidon-4 i et inert or-ganisk oppløsningsmiddel, f. eks. benzol, toluol, xylol, tetraiin osv. omsatt med en forbindelse med formel III, fortrinsvis med en cyaneddåksyre-alkyl-ester, i nærvær av en vannavspaltende katalysator, f. eks. iseddik alene eller sammen med ammondumacetat, og under 'anvendelse av en kontinuerlig arbeidende vannutskiller, til en forbindelse med formel IV. Ved dobbelt-bindingen av dette derivat blir det tilleiret blåsyre, og den forbindelse med formel V som dannes blir forsåpet og dekarfaofcsylert med kons. saltsyre til en substituert ravsyre. Denne blir forestret med en abs. alkohol og klorhydrogen til en substituert ravsyre-diester med formel VI. Fremgangsmåten frem til diesteret med formel VI blir fortrinsvis gjennomført uten isolering henholdsvis rensing av de enkelte mellom-produkter. The method is carried out, for example, in the following way: A 1-alkyl-piperidone-4 in an inert organic solvent, e.g. benzene, toluene, xylol, tetrayl, etc. reacted with a compound of formula III, preferably with a cyanoacetic acid alkyl ester, in the presence of a water splitting catalyst, e.g. glacial acetic acid alone or together with ammondum acetate, and using a continuously operating water separator, to a compound of formula IV. During the double bond of this derivative, prussic acid is added, and the compound of formula V that is formed is saponified and decarfaofcylated with conc. hydrochloric acid to a substituted succinic acid. This is esterified with an abs. alcohol and hydrogen chloride to a substituted succinic acid diester of formula VI. The process up to the diester of formula VI is preferably carried out without isolation or purification of the individual intermediate products.
Det substituerte ravsyre-diester med formel VI kan nu overføres til det ønskete substituerte succinimid med formel I ved omsetning med kons. vandig ammoniakk eller at primært alkylamin, f. eks. flytende metylamin, etylamin osv., fortrinsvis i luk-ket kar. Da det 1 det siste reaksjonstrinn først dannes et substituert ravsyre-diamid-derivat, må reatosjonsblandingen for å opp-nå ringslutn-ing av diamidet tilslutt oppvarmes til høy temperatur, f. eks. 180— 250°. The substituted succinic diester of formula VI can now be transferred to the desired substituted succinimide of formula I by reaction with conc. aqueous ammonia or that primary alkylamine, e.g. liquid methylamine, ethylamine etc., preferably in a closed vessel. As a substituted succinic acid-diamide derivative is first formed in the last reaction step, the reaction mixture must finally be heated to a high temperature to achieve ring closure of the diamide, e.g. 180— 250°.
De nye substituerte succinimider med formel I er farveløse forbindelser, som ved romtemperatur er oljeaktige eller faste krystallinske. De lar seg lett oppløse i van-lige organiske oppløsningsmidler, men ikke i vann. Med anorganiske eller organiske syrer danner de stabile salter som er krystallinske ved romtemperatur og som lett lar seg oppløse i vann. The new substituted succinimides of formula I are colorless compounds, which at room temperature are oily or solid crystalline. They dissolve easily in common organic solvents, but not in water. With inorganic or organic acids, they form stable salts which are crystalline at room temperature and which can easily dissolve in water.
De nye forbindelser har Interessante, terapeutisk verdifulle, farmakodynamiske egenskaper, som delvis skyldes en cholin-ergisk virkningstype. Således utmerker f. eks. spiro- (l-metyl-plperidyl-4) -N-metyl-succinimM og det tilsvarende -N-etyl-suc-cinlmid seg ved en omfattende parasym-påtikomimetisk virkning, som ytrer seg perifert eller sentralt. De virker blodtrykk-senkende og pulsfrekvens-senkende på dyr. Samtidig øker motiliteten for tynntarmen og urinblæren og spyttfloden samt mave-saf tsekresj onen blir fremmet sterkt. De sentrale cholinergiske effekter ytrer seg i en utpreget narkosepotensering, en tydelig analgesi samt i en hemning av betingete reflekser. Det dreier seg herunder om pa-rasympatikomimetiske effekter, da også de sentrale virkninger blir hemmet eller opphevet ved hjelp av store doser av hy-oscyamin og andre sentralt virkende an-tichollnergika. På grunn av sine opphis-sende egenskaper på mavetarmvirksomhe-ten og urinblærefunksj onen skal de nye forbindelser 'brukes for behandling av mave-og tarm-sykdommer samt innføres 1 uro-logien. Samtidig kan de torukes for berolig-else og for 'behandling av psykiske forstyr-relser samt av smertetilstander. De utgjør videre verdifulle 'mellomprodukter for fremstilling av medikamenter. The new compounds have interesting, therapeutically valuable, pharmacodynamic properties, which are partly due to a cholinergic mode of action. Thus, e.g. spiro-(1-methyl-plperidyl-4)-N-methyl-succinimide and the corresponding -N-ethyl-succinimide by an extensive parasympathomimetic action, which manifests itself peripherally or centrally. They have a blood pressure-lowering and pulse-rate-lowering effect on animals. At the same time, the motility of the small intestine and urinary bladder increases and the flow of saliva and gastric juice secretion are strongly promoted. The central cholinergic effects manifest themselves in a pronounced potentiation of anesthesia, a clear analgesia and in an inhibition of conditioned reflexes. These include parasympathomimetic effects, as the central effects are also inhibited or abolished by means of large doses of hyoscyamine and other centrally acting anticholinergics. Due to their stimulating properties on gastrointestinal activity and urinary bladder function, the new compounds are to be used for the treatment of gastrointestinal diseases and introduced into urology. At the same time, they can be used for sedation and for the treatment of mental disorders as well as pain conditions. They also constitute valuable 'intermediate products for the manufacture of drugs.
Det skal nu gis noen eksempler på hvorledes fremgangsmåten kan gjennom-føres, idet herunder alle temperaturer er angitt i celsiusgrader. Smelte- og koke-punktene er ikke korrigert. Some examples will now be given of how the method can be carried out, with all temperatures being indicated in degrees Celsius. The melting and boiling points are not corrected.
Eksempel 1. Example 1.
Spiro-( l- metyl- piperidyl- 4) - succinimid. Spiro-(1-methyl-piperidyl-4)-succinimide.
(8-metyl-2,8-diazasplro [4,5] dekan-1,3-dion) a) ( 1 - metyl- piperidyliden- 4)- cyaneddiksyre- etylester. (8-methyl-2,8-diazaspro [4,5] decane-1,3-dione) a) (1-methyl-piperidylidene-4)-cyanoacetic acid ethyl ester.
113,0 ig cyanetidiksyre-etylester, 113,0 g l-metyl-piperldon-4 og 23 ems iseddik ble 113.0 ig of cyanoethylacetic acid ethyl ester, 113.0 g of 1-methyl-piperldone-4 and 23 ems of glacial acetic acid were
kokt i fire timer i 250 ems benzol. Det vann som tole uvspaltet under reaksjonen ble fjernet kontinuerlig fra tiltoakeløpet ved hjelp av en vannutskiller. Etter 2i/2 time var det spaltet av 18 ems vann. Etter ytterligere l>/2 times koking ble det satt ytterligere 300 ems toenzol til og det hele ble rystet ut med 150 cm3 Iskold mettet pottaskeoppløsning. Pobtaskeoppløsnlngen ble ekstrahert ennu en gang med 150 ems benzol og toenzolekstrakten vasket en gang med 50 ems vann. Ettertørking over na-triumisulfat ble de forente toenzolekstrakter dampet av og den mørkfarvete kolberest destillert forsiktig i høyvakuum. Bare en liten overheting, f. eks. ved destilleringen bevirket betraktelig spalting. Rent (1 -metyl-piperidyliden-4) -cyaneddiksyreetyl-ester er en farveløs, viskos olje med kp. boiled for four hours in 250 ems benzol. The water which was separated during the reaction was removed continuously from the tillage run by means of a water separator. After 2½ hours there was a gap of 18 ems of water. After a further 1/2 hour of boiling, a further 300 ems toenzol was added and the whole was shaken out with 150 cm3 of ice-cold saturated pot ash solution. The pobash solution was extracted once more with 150 ems of benzene and the toluene extract washed once with 50 ems of water. After drying over sodium sulphate, the combined toenzole extracts were evaporated and the dark-coloured cob residue was carefully distilled in high vacuum. Just a little overheating, e.g. during the distillation caused considerable cleavage. Pure (1-methyl-piperidylidene-4)-cyanoacetic acid ethyl ester is a colorless, viscous oil with bp.
114—115°/0,05 mm Hg ,n <2>^'<5>= 1,4952. 114—115°/0.05 mm Hg ,n <2>^'<5>= 1.4952.
Hydrokloridet danner fine nåler med smp. 182—183° (sp) fra etanol. b) [( lmetyl- 4- karbetoksy- piperidyl)- 4] eddiksyre- etylester. 87,3 g (1-metyl-piperidyliden-4)-cyaneddiksyre-etylester og 42,5 g kaliumcyanid ble varmet opp på vanntoad sammen med 130 cm» 50 pst. etanol. Etter 10 min. ble det satt til ytterligere 15 ems vann og det hele fikk stå 1 ennu 5 min. på vannbadet. Oppløsningen som nu var klar, orangefar-vet ble kjølet til romtemperatur og under iskjøling tole det tilsatt 80 cm3 kons. saltsyre. Oppløsningen ble Inndampet ved vannstrålevakuum ved 60° til tørr tilstand, resten ble opptatt i 150 ems vann og den vandige oppløsning tole mettet med klorhydrogengass under iskjøling. Så ble det foretatt koking i 20 timer ved tilbakeløp og ny inndamping til tørr tilstand. Den farveløse, krystallinske rest ble tørket i 60 timer over fosforpentofcsyd, oppslem-met i 500 cm» etanol som var tørket over kalsiumoksyd og oppslemmingen mettet under iskjøling med tørr klorhydrogengass og kokt i 15 timer ved tilbakeløp. Deretter ble det foretatt inndamping 1 nitrogenat-mosfære ved vannstrålevakuum ved 60° til <i>/4 av det opprinnelige volum, fortynning under god kjøling med den dobbelte mengde vann, metting med kaliumkarbonat og ekstrahering 3 ganger hver gang med 250 ems kloroform. Kloroformekstraktene ble vasket en gang med vann og tørket over natriumsulfat. Etter fordamping av klo-roformen tole den oljeaktige kolberest destillert i høyvakuum. Ren [(l-metyl-4-karbetoksy-piper idyl) -4] -eddiksyre-etyl ester er en f arveløs olje med kp. 95—96/ 20 *i The hydrochloride forms fine needles with m.p. 182-183° (mp) from ethanol. b) [(1methyl-4-carbethoxy-piperidyl)-4]acetic acid ethyl ester. 87.3 g of (1-methyl-piperidylidene-4)-cyanoacetic acid ethyl ester and 42.5 g of potassium cyanide were heated on a water bath together with 130 cm" of 50% ethanol. After 10 min. a further 15 ems of water was added and the whole thing was allowed to stand for 1 more 5 min. in the water bath. The solution, which was now clear and orange in colour, was cooled to room temperature and, under ice cooling, 80 cm3 conc. hydrochloric acid. The solution was evaporated by water jet vacuum at 60° to a dry state, the residue was taken up in 150 ems of water and the aqueous solution was saturated with chlorine hydrogen gas under ice cooling. Boiling was then carried out for 20 hours at reflux and further evaporation to dryness. The colorless, crystalline residue was dried for 60 hours over phosphorus pentofcyde, slurried in 500 cc of ethanol which had been dried over calcium oxide and the slurry saturated under ice-cooling with dry chlorine hydrogen gas and boiled for 15 hours at reflux. Evaporation was then carried out in 1 nitrogen atmosphere under a water jet vacuum at 60° to <i>/4 of the original volume, dilution under good cooling with double the amount of water, saturation with potassium carbonate and extraction 3 times each time with 250 ems chloroform. The chloroform extracts were washed once with water and dried over sodium sulfate. After evaporation of the chloroform, the oily residue is distilled under high vacuum. Pure [(1-methyl-4-carbethoxy-piperidyl)-4]-acetic acid-ethyl ester is a colorless oil with bp. 95—96/ 20 *i
0,06 mm Hg. n ^ = 1,4582. Pikrat. Ka-narigule nåler fra etanol, smp. 135—136°. 0.06 mmHg. n ^ = 1.4582. Pikrat. Canary yellow needles from ethanol, m.p. 135-136°.
c) Spiro-( l- metyl- piperidyl- 4)- succinimid 6,6 g [(l-metyl-4-karbetoksy-piperidyl)-4]-eddiksyreetylester ble kokt sammen med 50 cm3 kons. vandig ammoniakk i 46 timer ved tilbakeløp. Etter 5 timer var c) Spiro-(1-methyl-piperidyl-4)-succinimide 6.6 g [(1-methyl-4-carbethoxy-piperidyl)-4]-acetic acid ethyl ester was boiled together with 50 cm3 conc. aqueous ammonia for 46 hours at reflux. After 5 hours was
den opprinnelig uoppløste ester gått full-stendig i oppløsning. Den svakt gulfarvete reaksj onsoppløsning ble inndampet til tørr tilstand ved vannstrålevakuum ved 60° til tørr tilstand. Den krystallinske kolberest ble så oppvarmet i 3 timer til 200°, så opptatt i vann og filtrert gjennom vatt. Filtratet ble inndampet til tørr tilstand og kolberesten oppløst i metanol. Oppløsningen ble iblandet med tørr brom-hydrogengass, hvorunder hydrobromidet av det søkte spiro-(l-metyl-piperidyl-4)-succinimid tole felt ut i farveløse små pla-ter. Etter omkrystallisering fra metanol smeltet det svakt hygroskopiske hydrobromid ved 311—313° (sp). the originally undissolved ester has completely dissolved. The slightly yellow reaction solution was evaporated to dryness under a water jet vacuum at 60° to dryness. The crystalline flask residue was then heated for 3 hours at 200°, then taken up in water and filtered through cotton wool. The filtrate was evaporated to dryness and the carbon residue dissolved in methanol. The solution was mixed with dry bromine-hydrogen gas, during which the hydrobromide of the desired spiro-(1-methyl-piperidyl-4)-succinimide tole precipitated in colorless small plates. After recrystallization from methanol, the slightly hygroscopic hydrobromide melted at 311-313° (sp).
Eksempel 2. Example 2.
Spiro- ( 1 - metyl- piperidyl- 4) - N-metyl- succinimid. Spiro-(1-methyl-piperidyl-4)-N-methyl-succinimide.
(2,8-dimetyl-2,8-diazaspiro [4,5] de-kan-l,3-dion). (2,8-dimethyl-2,8-diazaspiro[4,5]decane-1,3-dione).
Først tole det fremstilt (1-metyl-piper-idyllden-4) -cyaneddiiksyre-etylester slik som angitt 1 eksempel 1 under a) og over-ført til [ (l-metyl-4-karbetofcsy-piperidyl)-4]-eddiksyreetylester slik som angitt i eksempel 1 under b). 59,5 g av denne ester ble oppvarmet sammen med et overskudd av flytende 100 pst. metylamin i 12 timer i trykk-kar ved 140°. Så tole det foretatt avkjøling og overskuddet av metylamin fikk fordampe. Den krystallinske kolberest tole oppvarmet til 185°, hvorunder metylamin ble avspaltet under smelting. Etter 2i/2 time var metylaminutvlkllngen avslut-tet. Ved avkjølingen utkrystalliserte kolberesten. Den ble opptatt i 2-n. saltsyre, ekstrahert med eter og den saltsure oppløs-ning gjort alkalisk ved tilsetting av fast kaliumkarbonat. Det ibunnfall som herunder ble dannet ble ekstrahert med metyl-enklorid, uttrkket vasket en gang med vann og tørket over natriumsulfat. Etter fordampning av oppløsningsmiddelet ble det tilbake en farveløs, krystallinsk rest av spiro-(l-metyl-piperidyl-4)-N-metyl-suc-cinimld. Forbindelsen lar seg lett subli-mere med «utolimerlngspunkt 80°/0,01 mm Hg, smp. 94—96°. First, the prepared (1-methyl-piper-idylden-4)-cyanoacetic acid ethyl ester as indicated in Example 1 under a) and transferred to [(1-methyl-4-carbethoxy-piperidyl)-4]-acetic acid ethyl ester as stated in example 1 under b). 59.5 g of this ester were heated together with an excess of liquid 100% methylamine for 12 hours in a pressure vessel at 140°. Cooling was then carried out and the excess methylamine was allowed to evaporate. The crystalline carbon residue was heated to 185°, below which methylamine was split off during melting. After 2½ hours the methylamine evolution was complete. During cooling, the carbon residue crystallized. It was occupied in 2-n. hydrochloric acid, extracted with ether and the hydrochloric acid solution made alkaline by the addition of solid potassium carbonate. The precipitate that formed below was extracted with methylene chloride, extracted, washed once with water and dried over sodium sulfate. After evaporation of the solvent, a colorless, crystalline residue of spiro-(1-methyl-piperidyl-4)-N-methyl-succinyl was left. The compound can be easily sublimated with a melting point of 80°/0.01 mm Hg, m.p. 94-96°.
Hydrokloridet som ble fremstillet i etanol ble omkrystallisert fra metanol; svakt hygroskopiske, farveløse prismer med smp. 318—319° (sp). The hydrochloride prepared in ethanol was recrystallized from methanol; weakly hygroscopic, colorless prisms with m.p. 318—319° (sp).
Fumarat: Ekvivalente mengder av succinimid-derivatet og fumarsyre (1 mol : 1 mol) hie kokt opp sammen i etanol. Etter avkj øling ble det foretatt filtrering og krystallisering fra metanol/vann. Farveløse polyeder med smp. 266° (sp). Fumarate: Equivalent quantities of the succinimide derivative and fumaric acid (1 mol : 1 mol) were boiled together in ethanol. After cooling, filtration and crystallization from methanol/water were carried out. Colorless polyhedra with m.p. 266° (sp).
Pikrat: Overskytende etanolisk pik-rinsyreoppløsning ble kokt opp i kort tid sammen med sucoinimidderivatet. Ved av-kjøling utkrystalliserte pikratet i fine gule prismer. Omkrystallisering fra etanol/ vann. Smp. 260° (sp) etter sintring ved 216°. Picrate: Excess ethanolic picric acid solution was boiled for a short time together with the sucoinimide derivative. On cooling, the picrate crystallized in fine yellow prisms. Recrystallization from ethanol/water. Temp. 260° (sp) after sintering at 216°.
Eksempel 3. Example 3.
Spiro- ( l- metyl- piperidyl- 4) - N-etyl- succinimid. Spiro-(1-methyl-piperidyl-4)-N-ethyl-succinimide.
(2-etyl-8-metyl-2,8-diazasplro [4,5] dekan-l,3-dion). (2-ethyl-8-methyl-2,8-diazaspro[4,5]decane-1,3-dione).
Først ble [(l-metyl-4-karbetoksy-piperidyl) -4] -eddiksyreetylester fremstillet slik som angitt 1 eksempel 1 under a) og to). First, [(1-methyl-4-carbethoxy-piperidyl)-4]-acetic acid ethyl ester was prepared as indicated in Example 1 under a) and two).
15,0 g av denne ester tole oppvarmet sammen med 15 cm» etylamin 1 40 timer i igjensmeltet rør til 150°. Det overskytende amin ble fordampet i vannstrålevakuum ved 40° og det utkrystalliserte råprodukt destillert 1 høyvakuum. Spiro-(l-metyl-piperidyl-4)-N-etyl-succinimid kokte ved 79° under 0,04 mm Hg. 15.0 g of this ester were heated together with 15 cm" of ethylamine 1 for 40 hours in a remelted tube to 150°. The excess amine was evaporated in a water jet vacuum at 40° and the crystallized crude product distilled under high vacuum. Spiro-(1-methyl-piperidyl-4)-N-ethyl-succinimide boiled at 79° under 0.04 mm Hg.
Hydrokloridet ble oppnådd ved å tolan-de den alkaliske oppløsning av den fri toase med en oppløsning av etanolisk saltsyre. Fra etanol farveløse prismer med smp. 255°. The hydrochloride was obtained by diluting the alkaline solution of the free toase with a solution of ethanolic hydrochloric acid. From ethanol colorless prisms with m.p. 255°.
Hydrobromidet tole oppnådd på tilsvarende måte og smeltet ved 302—304° etter omkrystallisering fra etanol. The hydrobromide tole obtained in a similar manner and melted at 302-304° after recrystallization from ethanol.
Fumarat: En konsentrert vandig opp-løsning av -fumarsyre tole blandet med en ekvivalent mengde av succinimidderivatet (1 mol : 1 mol). Det tole tilsatt litt etanol og den f arveløse oppløsning tole inndampet til tørr tilstand. Resten tole omkrystallisert fra etanol/vann. Farveløse polyeder med smp. 204—206°. Fumarate: A concentrated aqueous solution of -fumaric acid tole mixed with an equivalent amount of the succinimide derivative (1 mol : 1 mol). A little ethanol was added to it and the colorless solution was evaporated to dryness. The residue tole recrystallized from ethanol/water. Colorless polyhedra with m.p. 204—206°.
Pikrat: Overskytende etanol.sk pikrin-syreoppløsning tole satt til det fri succlni-mid-derivat og kokt opp i kort tid. Etter avkjøling tole det foretatt avfiltrering og omkrystallisering tre ganger fra etanol/ vann. Smp. 214—217°. Picrate: Excess ethanol.sk picric acid solution tole added to the free succlnimid derivative and boiled for a short time. After cooling, filtration and recrystallization were carried out three times from ethanol/water. Temp. 214—217°.
Eksempel 4. Example 4.
Spiro- ( piperidyl- 4 ) - N'- metyl- succinimid. Spiro-(piperidyl-4)-N'-methyl-succinimide.
2-metyl-2,8-diazaspiro [4,5] dekan-1,3-dion). a) ( l- bemyl- piperidyliden- 4) - cyaneddiksyre- etylester. 50 g cyaneddiksyre-etylester, 70,48 g 1-benzyl-piperidon-4, 12 ems iseddik og 4 g ammondumacetat tole kokt sammen 1 400 ems benzol i 7 timer ved tilbakeløp. Det vann som tole dannet tole fjernet kontinuerlig fra tiltoakeløpet ved hjelp av an vann-avskiller. Etter 7 timer var det spaltet av 7 cm?>.Reaksj onsblandingen ble,etter å væ-re avkjølet med isvann, rystet ut en gang med mettet pottaskeoppløsning og den vandige fase ettervasket en gang med benzol. De forente benzollag ble vasket en gang med vann, tørket over natriumsulfat og inndampet. Den mørkfarvete kolberest, som bestod av rå (1-toenzyl-piperidyliden-4) -cyaneddiksyre-etylester, utkrystalliserte fullstendig ved avkjøling. Este-ren kan anvendes direkte uten ytterligere rensing. Fra eter/petroleter dannet den gulf arvete krystaller med smp. 70—71°. 2-methyl-2,8-diazaspiro[4,5]decane-1,3-dione). a) (l-bemyl-piperidylidene-4)-cyanoacetic acid ethyl ester. 50 g cyanoacetic acid ethyl ester, 70.48 g 1-benzyl-piperidone-4, 12 ems glacial acetic acid and 4 g ammondum acetate were boiled together in 1,400 ems benzene for 7 hours at reflux. The water that formed tole was continuously removed from the tillage run by means of a water separator. After 7 hours, it was separated by 7 cm?>. The reaction mixture was, after being cooled with ice water, shaken out once with a saturated potash solution and the aqueous phase washed once with benzene. The combined benzene layers were washed once with water, dried over sodium sulfate and evaporated. The dark-colored carbon residue, which consisted of crude (1-toenzyl-piperidylidene-4)-cyanoacetic acid ethyl ester, completely crystallized on cooling. The ester cleaner can be used directly without further purification. From ether/petroleum ether it formed yellow crystals with m.p. 70-71°.
to) [ ( 1 - benzyl- 4- karbetoksy- piper idyl)-4]- eddiksyre- etylester. two) [ ( 1 - benzyl- 4- carbethoxy-piperidyl)-4]- acetic acid ethyl ester.
Ovenstående kolberest tole oppløst i 500 cm3 etanol, 250 cm3 vann tole tilsatt og oppløsningen oppvarmet på kokende vanntoad. Under oppvarmingen ble det tilsatt 31 g kalsiumcyanid som straks opp-løser seg ved omrøring. Etter at alt var oppløst, ble temperaturen holdt på 75° i 12—15 min., hvoretter 250 cm3 2-n. saltsyre tole tilsatt og oppløsningen inndampet ved vannstrålevakuum til tørr tilstand. Deretter ble det tilsatt 750 cm3 HC1, kokt i 14 timer ved tilbakeløp, avkjølet og filtrert. Filtratet tole inndampet til tørr tilstand og koltoeresten og filterresten tør-ket 1 60 timer over fosforpentoksyd. Om den tørkete krystallmasse ble det så helt 500 ems etanol og under iskjøling ble det innført klorhydrogengass Inntil metning. Det tole foretatt koking i 18 timer ved til-bakeløp, reaksj onsblandingen ble avkjølt og filtrert. Filtratet tole igjen inndampet til tørr tilstand, koltoeresten og filterresten ble oppløst i isvann og et overskudd av pottaske ble satt til oppløsningen. Så tole det foretatt ekstrahering tre ganger med eter og eterekstraktene tole vasket hver gang med vann. Etter at eterekstrakten var tørket over natriumsulfat ble den inndampet og den oljeaktige kolberest tole destillert i kulerør. [(l-benzyl-4Jkarbetoksy-piperidyl)-4]-eddiksyre-etylester kokte ved 150° under 0,03 mm Hg (temperatur målt i luftbadet); svakt gulf arvet olje. c) Spiro-( benzyl- piperidyl- 4) - N- metyl-succinimid. The above cob residue was dissolved in 500 cm3 of ethanol, 250 cm3 of water was added and the solution was heated over boiling water. During the heating, 31 g of calcium cyanide was added, which immediately dissolves on stirring. After everything had dissolved, the temperature was kept at 75° for 12-15 min., after which 250 cm3 2-n. hydrochloric acid tole added and the solution evaporated by water jet vacuum to dryness. Then 750 cm 3 of HC1 were added, boiled for 14 hours at reflux, cooled and filtered. The filtrate was evaporated to dryness and the carbon residue and the filter residue were dried over phosphorus pentoxide for 160 hours. About the dried crystal mass, 500 ems of ethanol were added and, under ice cooling, chlorine hydrogen gas was introduced until saturation. Boiling was carried out for 18 hours at reflux, the reaction mixture was cooled and filtered. The filtrate was again evaporated to dryness, the charcoal residue and the filter residue were dissolved in ice water and an excess of pot ash was added to the solution. Extraction was then carried out three times with ether and the ether extracts were washed each time with water. After the ether extract had been dried over sodium sulphate, it was evaporated and the oily cob residue was distilled in a ball tube. [(1-Benzyl-4H-carbethoxy-piperidyl)-4]-acetic acid ethyl ester boiled at 150° below 0.03 mm Hg (temperature measured in the air bath); weak gulf inherited oil. c) Spiro-(benzyl-piperidyl-4)-N-methyl-succinimide.
15,0 g [(l-benzyl-4-kartoetoksy-piperidyl)-4]-eddiksyreetylester tole oppvarmet sammen med et overskudd av flytende metylamin i 12 timer 1 stålautoklav ved 180°. Det overskytende metylamin tole så fordampet og den krystallinske kolberest oppvarmet i ytterligere 4 timer til 200°, inntil produktet, som var smeltet ved denne temperatur, ikke viste ytterligere tolæredan-nelse. Stoffet tole opptatt i litt etanol, kokt i kort tid med litt aktivt kull og filtrert. Ved avkjøling ble spiro-(1 -toenz<y>l-<p>iperid-yl-4)-N-metyl-succinimid utfelt i store farveløse prismer med smp. 111—112°. 15.0 g of [(1-benzyl-4-cartoethoxy-piperidyl)-4]-acetic acid ethyl ester were heated together with an excess of liquid methylamine for 12 hours in a steel autoclave at 180°. The excess methylamine tole was then evaporated and the crystalline carbon residue heated for a further 4 hours at 200°, until the product, which had melted at this temperature, showed no further tole formation. The substance tole absorbed in a little ethanol, boiled for a short time with a little activated charcoal and filtered. On cooling, spiro-(1-toenz<y>l-<p>iperid-yl-4)-N-methyl-succinimide was precipitated in large colorless prisms with m.p. 111-112°.
Hydroklorid. Fra etanol farveløse prismer med smp. 254—256°. d) Spiro-( piperidyl- 4)- N- metyl-succinimid. Hydrochloride. From ethanol colorless prisms with m.p. 254—256°. d) Spiro-(piperidyl-4)-N-methyl-succinimide.
3,0 g spiro-(l-benz<y>l-piiperidyl-4)-N-metyl-succinimid i 100 cm?> etanol tole hy-drert med 300 mg palladium på aktivt kull (10 pst.) i 12 timer under normaltrykk ved romtemperatur. Hydrogenopptagelsen var 315 cma (= 114 pst.). Etter at etanolet var fordampet ble det rå spiro-(piperidyl-4)-N-metyl-succinimid destillert i kulerør i høyvakuum kp. 99°/0,02 mm Hg (temperatur målt i luftbadet). Det var et sterkt hygroskopisk stoff som krystalliserte i rett-vinklete prismer med smp. 67°. 3.0 g of spiro-(l-benz<y>l-piperidyl-4)-N-methyl-succinimide in 100 cm?> ethanol tole hydrated with 300 mg of palladium on activated carbon (10 percent) for 12 hours under normal pressure at room temperature. The hydrogen uptake was 315 cma (= 114 per cent). After the ethanol had evaporated, the crude spiro-(piperidyl-4)-N-methyl-succinimide was distilled in a ball tube in high vacuum bp. 99°/0.02 mm Hg (temperature measured in the air bath). It was a strongly hygroscopic substance that crystallized in right-angled prisms with m.p. 67°.
Hydrobromid: Sammenfiltrete, fine nåler med smp. 292—294° etter omkrystallisering fra etanol/vann. Hydrobromide: Entangled, fine needles with m.p. 292—294° after recrystallization from ethanol/water.
Eksempel 5. Example 5.
Spiro- ( piperidyl- 4)- succinimid. Spiro-(piperidyl-4)-succinimide.
(2,8-diazaspiro-[4,5]-dekan-l,3-dion). a) Spiro-( l- benzyl- piperidyl- 4)-succinimid. (2,8-diazaspiro-[4,5]-decane-1,3-dione). a) Spiro-(1-benzyl-piperidyl-4)-succinimide.
Etter samme fremgangsmåte som er beskrevet i eksempel 4, under a) ble det først fremstilt (l-toenzyl-plperidyliden-4)-cyan-eddiksyre-etylester. Gule krystaller med smp. 70—71° fra eter-petroleter. Following the same procedure as described in example 4, under a), (1-thoenzyl-plperidylidene-4)-cyano-acetic acid ethyl ester was first prepared. Yellow crystals with m.p. 70—71° from ether-petroleum ether.
Blåsyretilleiringen foregikk ved behandling med alkalicyanid slik som beskrevet i eksempel 4 under to). Det ble nu foretatt forsåpning med kons. saltsyre i bare 3 timer (det blir ikke lenger konsta-tert kulldioksydutvikling). Etter avkjøling ble det foretatt filtrering, filtratet ble inndampet til tørr tilstand og resten tørket godt over fosforpentoksyd. Forestringen foregikk med etanol/klorhy drogen ved romtemperatur. Reaksj onsbliandingen ble inndampet til tørr tilstand, resten opptatt i litt vann, gjort alkalisk med pottaske under iskjøling og ekstrahert med kloroform. Kloroformekstrakten ble konsentrert, hvorunder forbindelsen, som var befridd for oppløsningsmlddelet, utkrystalliserte. Det dreiet seg om [(l-benzyl-4-karbamoyl-piperidyl)-4]-eddifcsyre-etylester som ved oppvarming over smeltepunktet gikk over i det ønskete spiro-(l-toenzyl-piperidyl-4)-succinlmid. Smp. 185° etter krystallisering fra etanol. Hydroklorid: smp. 312° (sp) etter krystallisering fra etanol. The hydrocyanic acid deposition took place by treatment with alkali cyanide as described in example 4 under two). Saponification was now carried out with conc. hydrochloric acid for only 3 hours (carbon dioxide evolution is no longer detected). After cooling, filtration was carried out, the filtrate was evaporated to dryness and the residue was dried well over phosphorus pentoxide. The esterification took place with ethanol/hydrogen chloride at room temperature. The reaction mixture was evaporated to dryness, the residue taken up in a little water, made alkaline with pot ash under ice cooling and extracted with chloroform. The chloroform extract was concentrated, during which the compound, freed from the solvent, crystallized. It was about [(1-benzyl-4-carbamoyl-piperidyl)-4]-acetic acid ethyl ester which, when heated above the melting point, converted into the desired spiro-(1-thobenzyl-piperidyl-4)-succinimide. Temp. 185° after crystallization from ethanol. Hydrochloride: m.p. 312° (sp) after crystallization from ethanol.
b) Spiro- ( piperidyl- 4) - succinimid. b) Spiro-(piperidyl-4)-succinimide.
En forbindelse som er oppnådd slik A compound thus obtained
som beskrevet ovenfor ble underkastet en katalytisk hydrering for å spalte av benzylgruppen. Hydrerlngen ble foretatt slik som beskrevet i eksempel 4 under d). Spiro-(piperidyl-4)-succinimid smeltet ved 243—244° (sp) etter omkrystallisering fra etanol. Hydroklorid: smp. 356° (sp) etter omkrystallisering fra etanol/vann. as described above was subjected to a catalytic hydrogenation to cleave off the benzyl group. The hydrogenation was carried out as described in example 4 under d). Spiro-(piperidyl-4)-succinimide melted at 243-244° (sp) after recrystallization from ethanol. Hydrochloride: m.p. 356° (sp) after recrystallization from ethanol/water.
Eksempel 6. Example 6.
Spiro- ( l- etyl- piperidyl- 4) - N-etyl- succinimid. Spiro-(1-ethyl-piperidyl-4)-N-ethyl-succinimide.
(2,8-dietyl-2,8-diazaspiro[4,5]dekan-1,3-dion). (2,8-diethyl-2,8-diazaspiro[4,5]decane-1,3-dione).
Først ble det fra [(l-benzyl-4-karbetoksy-piper idyl) -4]-eddiksyre-etylester og etylamin fremstillet spiro- (1-toenzyl-piperidyl-4)-N-etyl-succinimid etter samme fremgangsmåte som den som er beskrevet i eksempel 4. Smp. 104—105° etter omkrystallisering fra etanol. First, spiro-(1-toenzyl-piperidyl-4)-N-ethyl-succinimide was prepared from [(1-benzyl-4-carbethoxy-piperidyl)-4]-acetic acid ethyl ester and ethylamine using the same procedure as that which is described in example 4. Smp. 104—105° after recrystallization from ethanol.
Avspaltingen av benzylgruppen foregikk på lignende måte som i foregående eksempel og førte til spiro-(piperidyl-4)-N-etyl-succinimid. Meget seig olje med smp. 107°/0,05 mm Hg. Forbindelsen krystalliserte ikke. The cleavage of the benzyl group took place in a similar manner as in the previous example and led to spiro-(piperidyl-4)-N-ethyl-succinimide. Very viscous oil with m.p. 107°/0.05 mm Hg. The compound did not crystallize.
13 g av forbindelsen, 25 ems nydestil-lert acetaldehyd, 75 cm?- etanol og 3 g Ra-neynikkel ble rystet i 24 timer under hydrogenatmosfære ved normaltrykk og romtemperatur. Det ble utført filtrering fra katalysatoren, oppløsningsmiddelet ble dampet av og resten ble destillert under nedsatt trykk. Den fraksj on som gikk over ved 132°/0,2 mm Hg dannet spiro-(l-etyl-piperidyl-4) -N-etyl-succinimid. Hydrobromidet smeltet ved 293° etter omkrystallisering fra metanol. 13 g of the compound, 25 ems of freshly distilled acetaldehyde, 75 cm3 ethanol and 3 g Raney nickel were shaken for 24 hours under a hydrogen atmosphere at normal pressure and room temperature. Filtration from the catalyst was carried out, the solvent was evaporated and the residue was distilled under reduced pressure. The fraction that transitioned at 132°/0.2 mm Hg formed spiro-(1-ethyl-piperidyl-4)-N-ethyl-succinimide. The hydrobromide melted at 293° after recrystallization from methanol.
Eksempel 7. Example 7.
Spiro- ( l- n- butyl- piperidyl- 4) - Spiro-(l-n-butyl-piperidyl-4)-
N- etyl- succinimid. N-ethyl succinimide.
(2-etyl-8-n-butyl-2,8-diazaspiro [4,5]dekan-l,3-dion). (2-ethyl-8-n-butyl-2,8-diazaspiro[4,5]decane-1,3-dione).
3,10 g spiro-(piperidyl-4)-N-etyl-suc- 3.10 g of spiro-(piperidyl-4)-N-ethyl-suc-
cinimid, fremstilt slik som beskrevet i eksempel 6 tole oppvarmet sammen med 2,17 g n-butyltoromid og 5 g natriumkarbonat i 25 ems n-toutanol i 24 timer ved tilbake-løp. Reaksj onsblandingen tole inndampet til tørr tilstand og resten opptatt i 2-n. saltsyre under kjøling. Den sure oppløs-ning ble rystet ut en gang med eter, gjort alkalisk med pottaske og ekstrahert med eter. Fra eterekstrakten tole hydrokloridet av spiro- (l-n-butyl-piperidyl-4) -N-etyl-succinimid fremstillet ved tilsetning av etanolsk saltsyre. Smp. 269° etter omkrystallisering fra etanol. cinimide, prepared as described in Example 6, was heated together with 2.17 g of n-butyl toramide and 5 g of sodium carbonate in 25 ems of n-tautonol for 24 hours at reflux. The reaction mixture was evaporated to dryness and the residue taken up in 2-n. hydrochloric acid while cooling. The acidic solution was shaken out once with ether, made alkaline with potash and extracted with ether. From the ether extract tole the hydrochloride of spiro-(1-n-butyl-piperidyl-4)-N-ethyl-succinimide prepared by the addition of ethanolic hydrochloric acid. Temp. 269° after recrystallization from ethanol.
Etter samme fremgangsmåte som angitt i de foregående eksempler, er det fremstillet forbindelser som, sammen med sine egenskaper, er angitt i vedføyde tabell. Following the same procedure as stated in the preceding examples, compounds have been produced which, together with their properties, are indicated in the attached table.
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21175871A | 1971-12-23 | 1971-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO135338B true NO135338B (en) | 1976-12-20 |
NO135338C NO135338C (en) | 1977-03-30 |
Family
ID=22788248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO4050/72A NO135338C (en) | 1971-12-23 | 1972-11-08 | PROCEDURES FOR MANUFACTURING AN EXPANDED EDIBLE PROTEIN PRODUCT. |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS4868767A (en) |
AU (1) | AU476095B2 (en) |
CA (1) | CA977606A (en) |
CH (1) | CH562571A5 (en) |
DE (1) | DE2260828A1 (en) |
ES (1) | ES409135A1 (en) |
FI (1) | FI53912C (en) |
FR (1) | FR2164628B1 (en) |
GB (1) | GB1389592A (en) |
IT (1) | IT1049262B (en) |
NL (1) | NL7216511A (en) |
NO (1) | NO135338C (en) |
SE (1) | SE397259B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3930045A (en) * | 1973-11-20 | 1975-12-30 | Nestle Sa | In situ production of meat like flavor in extruded porous food product |
DE2837294A1 (en) * | 1977-08-29 | 1979-03-15 | Sodes Sa | Food prods contg. bran, gluten and flour - prepd. continuously by extruding mixt. with water; used in diet bread, cereals, etc. |
DE2845571C2 (en) * | 1978-10-19 | 1985-05-02 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | High fiber extruded snack article |
EP0048533A1 (en) * | 1980-03-31 | 1982-03-31 | General Foods Corporation | Process for preparing meat analogs |
JPS6344848A (en) * | 1985-11-25 | 1988-02-25 | Ajinomoto Co Inc | Preparation of highly expanded food |
DE3690664T (en) * | 1985-12-27 | 1988-01-28 | ||
US5540932A (en) * | 1995-04-13 | 1996-07-30 | Purina Mills, Inc. | Extruded animal feed nuggets for ruminants |
WO2007001522A2 (en) * | 2005-06-17 | 2007-01-04 | Nusci Laboratories Llc | Stabilization of oxidized fats |
BE1024092B1 (en) * | 2014-09-05 | 2017-11-13 | Syral Belgium Nv | A PROTEINY MEAT REPLACEMENT WITH AN IMPROVED STRUCTURE AND EXTENDED SHELF LIFE. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3623885A (en) * | 1968-12-13 | 1971-11-30 | Archer Daniels Midland Co | Extrusion of proteinaceous materials |
-
1972
- 1972-11-06 GB GB5115972A patent/GB1389592A/en not_active Expired
- 1972-11-08 NO NO4050/72A patent/NO135338C/en unknown
- 1972-11-08 SE SE7214480A patent/SE397259B/en unknown
- 1972-11-08 CA CA155,953A patent/CA977606A/en not_active Expired
- 1972-11-13 AU AU48817/72A patent/AU476095B2/en not_active Expired
- 1972-11-30 ES ES409135A patent/ES409135A1/en not_active Expired
- 1972-12-01 FI FI3419/72A patent/FI53912C/en active
- 1972-12-06 NL NL7216511A patent/NL7216511A/xx not_active Application Discontinuation
- 1972-12-06 IT IT54537/72A patent/IT1049262B/en active
- 1972-12-11 CH CH1799272A patent/CH562571A5/xx not_active IP Right Cessation
- 1972-12-12 JP JP47124698A patent/JPS4868767A/ja active Pending
- 1972-12-13 DE DE2260828A patent/DE2260828A1/en active Pending
- 1972-12-14 FR FR7244547A patent/FR2164628B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FI53912C (en) | 1978-09-11 |
FI53912B (en) | 1978-05-31 |
FR2164628B1 (en) | 1979-04-27 |
SE397259B (en) | 1977-10-31 |
IT1049262B (en) | 1981-01-20 |
NO135338C (en) | 1977-03-30 |
AU4881772A (en) | 1974-05-16 |
AU476095B2 (en) | 1976-09-09 |
ES409135A1 (en) | 1976-11-16 |
CH562571A5 (en) | 1975-06-13 |
CA977606A (en) | 1975-11-11 |
GB1389592A (en) | 1975-04-03 |
DE2260828A1 (en) | 1973-06-28 |
FR2164628A1 (en) | 1973-08-03 |
NL7216511A (en) | 1973-06-26 |
JPS4868767A (en) | 1973-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU651695A3 (en) | Method of obtaining etherified oxybenzodigeterocycles, or their salts, or optically active antipodes | |
NO120938B (en) | ||
NO116055B (en) | ||
NO130878B (en) | ||
US3106578A (en) | Nu-phenethyl-2-phenylcyclopropylamine derivatives | |
NO154554B (en) | PROCEDURE FOR THE MANUFACTURING OF MINERAL BUILDING FIBERS. | |
NO135338B (en) | ||
DE3300774A1 (en) | NEW SPIROCYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AND NEW SPIROCYCLIC AMINO ACIDS AS INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF | |
NO166164B (en) | EQUIPMENT FOR AA ESTABLISH ELECTRICAL CONNECTION WITH A SINGLE SKIN ELECTRODE. | |
IE42119B1 (en) | Aralkylamine derivatives | |
CRONYN | AZABICYCLOALKANES. 2-AZABICYCLO [3· 3· 1] NONANE1, 2 | |
Mandell et al. | The Total Syntheses of d, l-Matrine and d, l-Leontine1 | |
US4010202A (en) | 5,6-Dihydroxy aminotetralol compounds | |
US3056796A (en) | 2.8-diazaspiro(4.5)decane-1.3 diones | |
US2500444A (en) | Uramidohomomeroquinene | |
NO141208B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 2- (PHENOXYALKYLTIO) IMIDAZOLE COMPOUNDS | |
CH301669A (en) | Process for the preparation of a morphine derivative. | |
US2266754A (en) | Synthesis of vitamin | |
SU586835A3 (en) | Method of preparing aminopropanol derivatives or their salts,racemates or optically active antipodes | |
DE2556143A1 (en) | 9-AMINOALKYL-9,10-DIHYDRO-9,10-METHANOANTHRACENE | |
NO143785B (en) | PROCEDURE FOR HEAT EXTRACTION OF ALUMINUM ALLOYS WITH HIGH STRENGTH | |
CH460773A (en) | Process for the preparation of substituted 3- (3-hydroxyphenyl) -1-phenacyl-piperidines | |
US3198800A (en) | 2, 8-(para-f-4-oxo-butyl)-diazaspiro[4, 5]-decane-1, 3-diones | |
US3127405A (en) | I-phenylalkyl | |
DE1211646B (en) | Process for the preparation of spirosuccinimides and their salts |